J Environ Manage
EcosystemEmigration and ImmigrationFishes
Dr. Michael Raymond Burgess, MD, PhD
NPI1083869242
- Part D claims, 2024
- 34
- Publications
- 19
- Clinical trials
- 4
- Hospital affiliations
- 1
- Medical groups
- 2
- Practice address
- 1001 Potrero Avenue, San Francisco, CA 94110
- Practice phone
- Call (415) 206-8000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Burgess' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael Raymond Burgess is a hematologist and oncologist in San Francisco, California
Dr. Burgess practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.
Dr. Burgess' NPI, 1083869242, was assigned on December 1, 2008. Dr. Burgess graduated from David Geffen School of Medicine at UCLA in 2007. Dr. Burgess holds California license A106128.
NPI and contact details
- NPI
- 1083869242NPI Registry (opens in a new tab)
- NPI enumeration date
- December 1, 2008
- NPI status
- Active
- Practice phone
- (415) 206-8000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 2007
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Michael Raymond Burgess practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California
Dr. Burgess' primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.
- Zuckerberg San Francisco General Hospital and Trauma Center1001 Potrero Avenue, San Francisco, CA 94110 · San Francisco CountyPhone(415) 206-8000
Source: Dmand AI Affiliation Data
Dr. Michael Raymond Burgess is affiliated with 3 sites of care and 2 medical groups
Dr. Burgess' primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. The medical group on file is UCSF Department of Radiology & Biomedical Imaging. Dmand AI also links Dr. Burgess to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Burgess' employer is on file too: a hospital.
UCSF Department of Radiology & Biomedical Imaging2 group practices and clinicsNames with a free account1 medical groupName with a free accountEmployer: hospitalName with a free account
See all 5 affiliations for Dr. BurgessSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michael Raymond Burgess' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burgess practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Zuckerberg San Francisco General Hospital and Trauma Center | Available with a free account |
| +2 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Burgess practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across City and County of San Francisco, CA and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael Raymond Burgess is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Burgess' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Burgess is board certified in hematology by the American Board of Internal Medicine. Dr. Burgess is licensed in California.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
Hematologists and oncologists near Dr. Burgess
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
1,502hematologists and oncologists in California61hematologists and oncologists in San Francisco6hematologists and oncologists at Zuckerberg San Francisco General Hospital and Trauma Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael Raymond Burgess' patients have a median age of 73
Across all payers, Dmand AI patient panel data puts Dr. Burgess' median patient age at 73, with 55% women.
Dr. Burgess' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women55%
- Men45%
Source: Dmand AI Patient Panel Data
Dr. Michael Raymond Burgess wrote 34 Medicare Part D claims in 2024
In 2024, Dr. Burgess wrote 34 Medicare Part D claims. 79% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $387 in total drug cost. In 2020, CMS named 11 claims across 1 drug.
Part D claims, 202434
Drugs named by CMS1
Total drug cost$387
Dr. Burgess' Part D claims by kind of drug, 2024
- Generic27 claims79%
- Brand-name and other7 claims21%
Dr. Burgess' most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2020 to 2023
- 2020
- 2023
- Claims for drugs CMS names
- 2020: 112023: 11No change
Drugs named by CMS: 1 in 2023, 1 in 2020.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Burgess by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael Raymond Burgess has 19 publications on record
Dmand AI links 19 papers to Dr. Burgess, published from 2006 to 2024. 2006 was the busiest year, with 2. The most frequent topics are Mass Spectrometry, Proteomics and Amino Acid Sequence. Dr. Burgess has published most often in Mol Cell Proteomics. Dr. Burgess' most frequent co-authors are Michael Andrew Gillette, MD, PhD, Charles L. Sawyers, MD and Benjamin Levine Ebert, MD.
Papers19
Years published2006 to 2024
Dr. Burgess' papers by year, 2006 to 2024
Topics Dr. Burgess writes about most
- Mass Spectrometry
- Proteomics
- Amino Acid Sequence
- Cell Proliferation
- DNA-Binding Proteins
- Drug Resistance, Neoplasm
- Fusion Proteins, bcr-abl
- Neoplasm Proteins
Dr. Burgess' most frequent co-authors
- Michael Andrew Gillette, MD, PhD3 shared papers
- Charles L. Sawyers, MD3 shared papers
- Benjamin Levine Ebert, MD2 shared papers
Recent publications by Dr. Burgess
Sci Rep
Fallopian TubesLong Interspersed Nucleotide ElementsOvarian Neoplasms
Cell Chem Biol
Binding SitesCells, CulturedDNA-Binding Proteins
See who Dr. Burgess researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Burgess works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael Raymond Burgess has worked on 4 clinical trials
Dmand AI links Dr. Burgess to 4 clinical trials, 4 of them phase 1 studies. Conditions studied include Hematologic Neoplasms, Multiple Myeloma and Myelodysplastic Syndromes. Celgene sponsors the most, 4.
Conditions in Dr. Burgess' trials
- Hematologic Neoplasms
- Multiple Myeloma
- Myelodysplastic Syndromes
- Blood Protein Disorders
- Hematologic Diseases
Recent clinical trials with Dr. Burgess
A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers (opens in a new tab)
TerminatedPhase 1
CC-95251CetuximabRituximab
Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma (opens in a new tab)
TerminatedPhase 1
Multiple MyelomaBlood Protein DisordersCC-93269
A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS) (opens in a new tab)
TerminatedPhase 1
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteCC-90002
A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers (opens in a new tab)
CompletedPhase 1
Hematologic NeoplasmsHematologic DiseasesCC-90002Rituximab
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael Raymond Burgess has 1 award and honors on record
Dmand AI lists 1 award for Dr. Burgess, most recently CMS Stage 1 EHR in 2014.
Awards and honors for Dr. Burgess
- 2014
- CMS Stage 1 EHR
Source: Dmand AI Professional Profile Data
Dr. Michael Raymond Burgess graduated from David Geffen School of Medicine at UCLA
Dr. Burgess graduated from David Geffen School of Medicine at UCLA in 2007. Dr. Burgess is a member of AOA, AACR, ASCO and ASH.
- Medical school
- Board certified in hematology
Source: Dmand AI Professional Profile Data
Dr. Michael Raymond Burgess accepts plans from 3 insurance carriers
Dr. Burgess is in network with 3 carriers, including Elevance, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.
- Elevance
- Blue Cross Blue Shield of Massachusetts
- HCSC
Plan types Dr. Burgess accepts, by number of carriers
- Medicare3
- PPO3
- EPO1
- HMO1
Source: Dmand AI Insurance Network Data
Sources for Dr. Michael Raymond Burgess's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael Raymond Burgess
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael Raymond Burgess' NPI number?
Dr. Michael Raymond Burgess' NPI number is 1083869242. It was assigned on December 1, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael Raymond Burgess?
Dr. Michael Raymond Burgess is a hematologist and oncologist in San Francisco, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Michael Raymond Burgess practice?
Dr. Burgess practices at 1001 Potrero Avenue, San Francisco, CA 94110. Dr. Burgess' primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. Dmand AI also links Dr. Burgess to 2 group practices and clinics and 1 medical group.
What is Dr. Michael Raymond Burgess' office phone number?
The practice phone on file for Dr. Burgess is (415) 206-8000.
What is Dr. Michael Raymond Burgess' medical license number?
Dr. Burgess holds California license A106128.
Which hospitals is Dr. Michael Raymond Burgess affiliated with?
Dr. Burgess practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California.
What medical group is Dr. Michael Raymond Burgess part of?
Dr. Burgess is linked to UCSF Department of Radiology & Biomedical Imaging. Dmand AI links Dr. Burgess to 1 more medical group.
Is Dr. Michael Raymond Burgess board certified?
Yes. Dr. Burgess is board certified in hematology by the American Board of Internal Medicine.
Where did Dr. Michael Raymond Burgess go to medical school?
Dr. Burgess graduated from David Geffen School of Medicine at UCLA in 2007.
What drugs does Dr. Michael Raymond Burgess prescribe most?
In 2023 Medicare Part D data, Dr. Burgess' most prescribed drugs by claims were Hydroxyurea.
Show 4 more questionsShow fewer questions
How long has Dr. Michael Raymond Burgess been practicing?
Dr. Burgess graduated from medical school in 2007, 19 years ago.
Does Dr. Michael Raymond Burgess do research?
Dmand AI links 19 publications to Dr. Burgess, published from 2006 to 2024. Dr. Burgess has worked on 4 clinical trials.
Who does Dr. Michael Raymond Burgess publish with?
Dr. Burgess' most frequent co-authors are Michael Andrew Gillette, MD, PhD (3 shared papers), Charles L. Sawyers, MD (3 shared papers) and Benjamin Levine Ebert, MD (2 shared papers).
What insurance does Dr. Michael Raymond Burgess accept?
Dr. Burgess is in network with 3 carriers, including Elevance, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card